|
|
Дата |
---|
03.04.2025 |
02.04.2025 |
01.04.2025 |
31.03.2025 |
28.03.2025 |
27.03.2025 |
26.03.2025 |
25.03.2025 |
24.03.2025 |
21.03.2025 |
Bid | Ask |
Open |
Min | Max |
Last |
Legal close |
Avg |
Оборот |
Кол-во сделок |
---|---|---|---|---|---|---|---|
15.17
|
15.42
|
15.28
|
15.09
|
15.37
|
15.19
|
|
|
65 394 904.99
|
20 649.00
|
14.62
|
14.92
|
15.00
|
14.89
|
15.065
|
14.98
|
|
|
16 661 069.98
|
8 635.00
|
14.62
|
15.16
|
15.00
|
14.88
|
15.02
|
14.90
|
|
|
20 522 440.42
|
9 273.00
|
14.66
|
15.08
|
14.87
|
14.75
|
14.96
|
14.87
|
|
|
26 219 579.09
|
10 596.00
|
13.75
|
15.25
|
15.12
|
14.89
|
15.12
|
15.05
|
|
|
14 071 602.29
|
6 986.00
|
14.76
|
15.25
|
14.97
|
14.97
|
15.1656
|
15.14
|
|
|
19 276 039.37
|
9 239.00
|
14.98
|
15.10
|
14.99
|
14.90
|
15.05
|
15.02
|
|
|
23 683 854.78
|
8 315.00
|
14.80
|
15.25
|
15.10
|
15.01
|
15.15
|
15.04
|
|
|
25 529 692.94
|
11 293.00
|
14.72
|
15.25
|
15.09
|
15.00
|
15.13
|
15.01
|
|
|
16 476 214.60
|
9 168.00
|
15.07
|
15.32
|
15.05
|
15.05
|
15.305
|
15.19
|
|
|
44 183 120.48
|
10 062.00
|
Период |
---|
2024, регулярные |
2024, регулярные |
2023, регулярные |
2022, регулярные |
2021, регулярные |
2021, регулярные |
2020, регулярные |
2020, регулярные |
2019, регулярные |
2019, регулярные |
Экс-дивидендная дата
|
Закрытие реестра |
Сумма выплаты |
---|---|---|
30.09.2024
|
30.09.2024 |
0.326079 USD |
27.03.2024
|
28.03.2024 |
0.292214 USD |
28.09.2023
|
29.09.2023 |
0.319068 USD |
30.03.2022
|
31.03.2022 |
0.2921 USD |
29.09.2021
|
30.09.2021 |
0.396898 USD |
30.03.2021
|
31.03.2021 |
0.406627 USD |
30.09.2020
|
30.09.2020 |
0.430533 USD |
30.03.2020
|
31.03.2020 |
0.419053 USD |
27.09.2019
|
30.09.2019 |
0.411118 USD |
28.03.2019
|
29.03.2019 |
0.417168 USD |
Takeda Pharmaceutical Company Limited operates as a research-based pharmaceutical company in Japan. The company’s drugs are marketed in approximately 90 countries worldwide. The company has an international marketing network, including Japan and 13 overseas bases in the U.S., Europe, and Asia. From these bases, the company markets its original products.The company operates its business in two categories, Pharmaceutical business and Other businesses. The Pharmaceutical business represents the ethical drug business and healthcare business. Other businesses include business activities involving the production and marketing of a range of products, including clinical diagnostics, photographic chemicals, and inorganic chemicals.
In November 2009, Amylin Pharmaceuticals Inc. and Takeda Pharmaceutical Co. Ltd. announced that they have entered into a worldwide exclusive license, development and commercialization agreement to co-develop and commercialize pharmaceutical products for the treatment of obesity and related indications.Takeda Pharmaceutical Company Limited was founded in 1781.
Показать все СкрытьНемецкая фармацевтическая группа Stada Arzneimittel AG приобретёт у японской Takeda Pharmaceutical Company Limited портфель из 20 брендовых продуктов, зарегистрированных в странах СНГ, за 660 миллионов долларов, говорится в сообщении...
Акционеры японской фармацевтической компании Takeda Pharmaceutical одобрили сделку по приобретению ирландской компании Shire на сумму 62 миллиарда долларов, следует из сообщения японской компании.Уточняется, что по итогам голосования,...